Dear Doctor Letter (Rote-Hand-Brief) on domperidone: serious cardiac side effects
2014.08.20
Active substance: domperidone
After conclusion of the European safety review of medicinal products containing domperidone, the marketing authorisation holders are circulating a joint Dear Doctor Letter with information on safety measures to minimise cardiac risks.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN